STOCK TITAN

Babcock & Wilcox (NYSE: BW) sells 12,432,432 shares in offering

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Babcock & Wilcox Enterprises entered into an underwriting agreement for an underwritten public offering of 10,810,811 shares of common stock at $18.50 per share. Underwriters received a 30‑day option for 1,621,621 additional shares, and closing on May 18, 2026 resulted in 12,432,432 shares issued in total, for gross proceeds of approximately $200 million before fees.

All shares are being offered by the Company under its effective shelf registration statement on Form S‑3. B&W plans to use net proceeds primarily to prepay amounts under its Credit Agreement, then reborrow to fund project capital and working capital, including AI data center power generation projects, potential acquisitions, growth initiatives, balance sheet strengthening and general corporate purposes.

Positive

  • None.

Negative

  • None.

Insights

Babcock & Wilcox raises about $200M in new equity to refinance debt and fund growth.

Babcock & Wilcox Enterprises completed an underwritten public offering of 10,810,811 common shares at $18.50 each, with underwriters fully exercising a 1,621,621‑share option, bringing total issuance to 12,432,432 shares and gross proceeds of about $200 million.

The transaction is a primary equity raise under an existing shelf registration, meaning cash flows to the Company rather than selling shareholders. Net proceeds are earmarked to prepay its Credit Agreement, then potentially reborrow to fund project capital, AI data center power generation initiatives, technology commercialization, acquisitions and other corporate purposes.

This mix of debt prepayment and planned reborrowing suggests a recapitalization aimed at managing near‑term obligations while funding growth projects. The overall impact for investors will depend on how effectively the new capital is deployed relative to the dilution from issuing 12,432,432 new shares.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Base shares offered 10,810,811 shares Underwritten public offering of common stock
Offering price $18.50 per share Price to the public for common stock offering
Gross proceeds Approximately $200 million Before underwriting discounts and offering expenses
Underwriters’ option shares 1,621,621 shares 30-day option, fully exercised
Total shares issued at closing 12,432,432 shares Including full exercise of underwriters’ option
Senior Notes coupon 6.50% Senior Notes due 2026 Existing debt security listed on NYSE
Preferred stock coupon 7.75% Series A Preferred Cumulative perpetual preferred stock listed on NYSE
underwritten public offering financial
"it priced an underwritten public offering of 10,810,811 shares of its common stock"
An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.
shelf registration statement on Form S-3 regulatory
"The shares of common stock were offered under the Company’s shelf registration statement on Form S-3"
A shelf registration statement on Form S-3 is a pre-approved filing with the Securities and Exchange Commission that lets an eligible public company register securities in advance and sell them later in one or more offerings without repeating the full registration process. Think of it like a pre-approved funding line: it gives management the flexibility to raise capital quickly when market conditions are right, a move that can affect share supply, dilution and investor returns, so investors monitor it as a signal of potential financing activity.
prospectus supplement regulatory
"made only by means of a preliminary prospectus supplement and accompanying base prospectus"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
Credit Agreement financial
"use the net proceeds of the Offering to prepay amounts outstanding under its Credit Agreement"
A credit agreement is a written loan contract between a borrower and a bank or other lender that lays out how much money can be borrowed, the interest rate, repayment schedule, fees, and the rules the borrower must follow. For investors, it matters because those terms affect a company’s cash costs, borrowing flexibility and risk of default — similar to how a mortgage’s rules determine a homeowner’s monthly budget and freedom to make changes.
forward-looking statements regulatory
"This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
cumulative perpetual preferred stock financial
"7.75% Series A Cumulative Perpetual Preferred Stock"
A cumulative perpetual preferred stock is a share that acts like a long-lasting hybrid between a bond and a dividend-paying stock: it promises regular fixed payments that, if missed, accumulate and must be paid later before common shareholders get dividends, and it has no set maturity date. Investors care because it can provide steady, higher-priority income similar to interest, but with limited capital upside, sensitivity to interest rates, and the risk that payments can be delayed even though they continue to accrue.
Offering Type shelf
Use of Proceeds Prepay amounts under the Credit Agreement, then reborrow to fund project capital and working capital, AI data center power generation projects, technology commercialization, potential acquisitions, balance sheet strengthening and general corporate purposes.
false 0001630805 DE OH 0001630805 2026-05-14 2026-05-14 0001630805 us-gaap:CommonStockMember 2026-05-14 2026-05-14 0001630805 BW:SeriesA7.75PercentageCumulativePerpetualPreferredStockMember 2026-05-14 2026-05-14 0001630805 BW:SeniorNotes6.50PercentageDue2026Member 2026-05-14 2026-05-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15 (d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 14, 2026

 

BABCOCK & WILCOX ENTERPRISES, INC.
(Exact name of registrant as specified in its charter)

 

DELAWARE   001-36876   47-2783641
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

 

1200 EAST MARKET STREET, SUITE 650
AKRON
, OHIO
  44305
(Address of principal executive offices)   (Zip Code)

 

Registrant’s Telephone Number, including Area Code: (330) 753-4511

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading
Symbol
  Name of Each Exchange on which
Registered
Common stock, $0.01 par value per share   BW   New York Stock Exchange
7.75% Series A Cumulative Perpetual Preferred Stock   BW PRA   New York Stock Exchange
6.50% Senior Notes due 2026   BWNB   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 1.01Entry into a Material Definitive Agreement

 

On May 14, 2026, Babcock & Wilcox Enterprises, Inc., a Delaware corporation (the “Company”) entered into an an underwriting agreement, dated May 14, 2026 (the “Underwriting Agreement”), by and among the Company and B. Riley Securities, Inc., as representative of the several underwriters (the “Underwriters”), relating to its previously announced underwritten offering (the “Offering”) of 10,810,811 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”). In addition, pursuant to the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 30 days, to purchase up to 1,621,621 additional shares of Common Stock. The Offering was consummated on May 18, 2026. At the closing, the Company issued 12,432,432 shares of Common Stock, inclusive of 1,621,621 shares of Common Stock issued pursuant to the full exercise of the Underwriters’ option to purchase Common Stock.

 

The Underwriting Agreement contains customary representations, warranties and covenants of the Company, customary conditions to closing, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933 (the “Securities Act”), other obligations of the parties and termination provisions.

 

The foregoing description of the material terms of the Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement, a copy of which is attached hereto as Exhibit 1.1 and is incorporated herein by reference.

 

The Offering was made pursuant to the Company’s shelf registration statement on Form S-3 (Registration No. 333-283368) initially filed with the Securities and Exchange Commission (the “Commission”) on November 21, 2024 and declared effective by the Commission on April 8, 2025 (the “Registration Statement”), including the prospectus forming a part of the Registration Statement, as supplemented by a preliminary prospectus supplement, dated May 14, 2026, and a final prospectus supplement, dated May 14, 2026, each filed with the SEC pursuant to Rule 424(b) under the Securities Act.

 

Item 7.01Regulation FD Disclosure

 

On May 15, 2026, the Company issued a press release announcing the pricing of the offering of Common Stock. A copy of the press release is filed as Exhibit 99.1 to this report and is incorporated herein by reference.

 

The information in this Item 7.01, including Exhibits 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in any such filing.

 

This Current Report on Form 8-K does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act.

 

Item 9.01.Financial Statements and Exhibits

 

(d)       Exhibits. 

 

Exhibit No.   Description
1.1   Underwriting Agreement, dated May 14, 2026
5.1   Opinion of O’Melveny & Myers LLP
23.1   Consent of O’Melveny & Myers LLP (included in Exhibit 5.1)
99.1   Pricing Press Release dated May 15, 2026
104   The cover page from this Current Report on Form 8-K formatted in Inline XBRL

 

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BABCOCK & WILCOX ENTERPRISES, INC.
   
May 18, 2026 By:  /s/ Cameron Frymyer
    Cameron Frymyer
    Executive Vice President and Chief Financial Officer
(Principal Accounting Officer and Duly Authorized Representative)

 

 

 

Exhibit 99.1

 

 

 

News Release

Babcock & Wilcox Enterprises Announces Pricing of Common
Stock Offering

 

(AKRON, Ohio – May 15, 2026) – Babcock & Wilcox Enterprises, Inc. (“B&W” or the “Company”) (NYSE: BW) announced that it priced an underwritten public offering of 10,810,811 shares of its common stock at a price to the public of $18.50 per share (the “Offering”), for gross proceeds of approximately $200 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Company has granted the underwriters a 30-day option to purchase up to an additional 15% of its common stock sold in the Offering at the public offering price, less underwriting discounts and commissions. All of the shares in the Offering are being offered by B&W. The Offering is expected to close on May 18, 2026, subject to customary closing conditions.

 

The Company intends to use the net proceeds of the Offering to prepay amounts outstanding under its Credit Agreement and subsequently reborrow such amounts under its Credit Agreement and use any such reborrowed amounts to fund project-related capital and working capital needs to influence steam turbine and boiler production capacity, support growth initiatives, including AI data center power generation projects and BrightLoopTM technology commercialization, potential acquisitions of aftermarket or other energy businesses, strengthen the Company’s balance sheet and for general corporate purposes.

 

B. Riley Securities is serving as the lead book-running manager for the Offering. Craig-Hallum and Lake Street Capital Markets are acting as joint book-running managers for the Offering. Northland Capital Markets is acting as co-manager for the Offering.

 

The shares of common stock were offered under the Company’s shelf registration statement on Form S-3, which was declared effective by the Securities and Exchange Commission (“SEC”) on April 8, 2025. The Offering was made only by means of a preliminary prospectus supplement and accompanying base prospectus, which were filed with the SEC. Copies of the preliminary prospectus supplement and the accompanying base prospectus for the Offering may be obtained on the SEC’s website at www.sec.gov, or by contacting B. Riley Securities, Inc. at 1655 Fort Myer Drive, Suite 1200, Arlington, Virginia 22209, Attention: Syndicate Prospectus Department, by telephone at 703-312-9580 or by email at prospectuses@brileysecurities.com.

 

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical or current fact included in this release are forward-looking statements. These forward-looking statements include, without limitation, statements regarding the Company’s public offering of common stock and intended use of net proceeds. You should not place undue reliance on these statements. Forward-looking statements include words such as “expect,” “intend,” “plan,” “likely,” “seek,” “believe,” “project,” “forecast,” “target,” “goal,” “potential,” “estimate,” “may,” “might,” “will,” “would,” “should,” “could,” “can,” “have,” “due,” “anticipate,” “assume,” “contemplate,” “continue” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operational performance or other events.

 

 

 

 

The forward-looking statements included herein are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events, or otherwise, except as required by law. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties, including, but not limited to: the potential for further conditions that could raise substantial doubt as to our ability to continue as a going concern, which has occurred in the past; our obligation to refinance or repay our 6.50% Senior Notes due 2026 prior to their maturity; risks associated with contractual pricing in our industry; disputes with customers with long-term contracts; the performance of third parties and subcontractors on whom we rely; disruptions at our or third-party manufacturing facilities; our ability to execute our growth strategy; our evaluation of strategic alternatives; our ability to deliver our backlog on time or at all; professional liability, product liability, warranty or other claims; inadequate insurance coverage; our ability to compete successfully against current and future competitors; our development of new products; cyclical and economic impacts on demand for our products; compliance with government regulations; legislative and regulatory developments impacting our business; supply chain issues; the financial and other covenants in our debt agreements; our ability to maintain adequate bonding and letter of credit capacity; impairment to our goodwill or other indefinite-lived intangible assets; our exposure to credit risk; disruptions in, or failures of, our information technology systems, including those related to cybersecurity; failure to comply with data and privacy laws, regulations and standards, or if we fail to properly maintain the integrity of our data, protect our proprietary rights to our systems or defend against cybersecurity attacks, we may be subject to government or private actions due to breaches; failure to protect our intellectual property rights, or inability to obtain or renew licenses to use intellectual property of third parties; uncertainty over tariffs and their impacts; sanctions and export controls; international political, economic and other uncertainties; fluctuations in the value of foreign currencies could harm our profitability; volatility of the market price and trading volume of our common stock; dilution of our common shareholders' ownership or voting power; the significant influence of BRC Group Holdings, Inc. over us; anti-takeover provisions in our corporate documents; changes in tax rates or tax law; our ability to use net operating losses and certain tax credits; failure to maintain effective internal control over financial reporting; new accounting pronouncements or changes in existing accounting standards and practices; our ability to attract and maintain key personnel; our relationship with labor unions; pension and medical expenses associated with our retirement benefits; natural disasters or other events beyond our control; and the risks and uncertainties described under the heading “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K and Part II, Item 1A of our Quarterly Reports on Form 10-Q as such risk factors may be amended, supplemented, or superseded from time to time by other reports we file with the SEC.

 

These forward-looking statements are made based upon detailed assumptions and reflect management’s current expectations and beliefs. While we believe that these assumptions underlying the forward-looking statements are reasonable, forward-looking statements are subject to uncertainties and factors relating to our operations and business environment that are difficult to predict and may be beyond our control. Such uncertainties and factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements.

 

About Babcock & Wilcox Enterprises
 

Headquartered in Akron, Ohio, Babcock & Wilcox Enterprises, Inc., is a leader in energy and environmental products and services for power and industrial markets worldwide. Follow us on LinkedIn and learn more at babcock.com.

 

# # #

 

Investor Contact: Media Contact:
Cameron Frymyer, Chief Financial Officer Ryan Cornell, Public Relations Lead
Babcock & Wilcox Enterprises, Inc. Babcock & Wilcox Enterprises, Inc.
330.860.6176 | investors@babcock.com 330.860.1345 | rscornell@babcock.com

 

 

 

FAQ

What did Babcock & Wilcox (BW) announce in this 8-K filing?

Babcock & Wilcox announced it priced and completed an underwritten public offering of common stock, issuing 12,432,432 shares in total. The deal was executed under its effective Form S-3 shelf registration and is intended to raise capital for debt prepayment and growth initiatives.

How many Babcock & Wilcox (BW) shares were offered and at what price?

The Company offered 10,810,811 shares of common stock at a public offering price of $18.50 per share. Underwriters also received, and fully exercised, a 30-day option to purchase 1,621,621 additional shares, bringing total shares issued at closing to 12,432,432.

What are the gross proceeds from Babcock & Wilcox’s (BW) stock offering?

The offering is expected to generate gross proceeds of approximately $200 million before underwriting discounts, commissions, and expenses. These proceeds provide fresh capital the Company plans to use for debt prepayment under its Credit Agreement and for funding project and growth-related spending.

How will Babcock & Wilcox (BW) use the net proceeds from this offering?

Babcock & Wilcox intends to use net proceeds to prepay amounts outstanding under its Credit Agreement, then reborrow to fund project capital and working capital, AI data center power generation projects, technology commercialization, potential acquisitions, balance-sheet strengthening, and general corporate purposes.

When is Babcock & Wilcox’s (BW) stock offering scheduled to close?

The Company stated the underwritten public offering is expected to close on May 18, 2026, subject to customary closing conditions. The subsequent 8-K narrative confirms the offering was consummated on that date, with all shares, including the underwriters’ option, issued at closing.

Under what registration statement did Babcock & Wilcox (BW) conduct this offering?

The shares were offered under Babcock & Wilcox’s shelf registration statement on Form S-3, Registration No. 333-283368. This registration statement was initially filed on November 21, 2024 and declared effective by the SEC on April 8, 2025, enabling the underwritten offering.

Filing Exhibits & Attachments

7 documents